BioRx Offers Free 2008 Kids Hemophilia Calendar.CINCINNATI -- BioRx, a specialty pharmaceutical company, announces the availability of a free 2008 calendar to the hemophilia community. The annual Kids Hemophilia Calendar features artwork from children who either have a bleeding disorder Bleeding disorder Problems in the clotting mechanism of the blood. Mentioned in: Lithotripsy bleeding disorder Coagulopathy, see there or have a sibling or parent with a bleeding disorder. To producer the calendar, BioRx sponsored a contest requiring entrants in three different age categories to submit artwork relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc their experiences in living with hemophilia. The company received more than 70 entries, which were judged on artistic merit and relevance to hemophilia. All contestants receive a prize and a copy of the calendar. Winning artwork is published in the calendar. "We are proud to support the hemophilia community by providing children with an outlet to express their thoughts and feelings about living with hemophilia in their family," said Eric Hill, co-founder of BioRx. "The winning entries this year express a level of creativity and compassion that is touching, and sometimes amusing." The 2008 Kids Hemophilia Calendar will be formally unveiled at the National Hemophilia Foundation Conference in Orlando, Nov. 1-3. To receive a complimentary copy of the calendar, contact BioRx at 866.44.BIORX (866.442.4679), via email at info@biorx.net, or via BioRx's website at www.biorx.net . About Hemophilia Hemophilia is an inherited bleeding disorder characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. About 17,000 Americans have hemophilia. The disease is caused by deficient or defective blood coagulation proteins, known as factor VIII factor VIII n. A factor in the clotting of blood, a deficiency of which is associated with hemophilia A. Also called antihemophilic factor, antihemophilic globulin, antihemophilic globulin A, or IX. The most common form of the disease is hemophilia A hemophilia A n. Hemophilia due to deficiency of factor VIII, characterized by prolonged clotting time, decreased formation of thromboplastin, and diminished conversion of prothrombin. , or classic hemophilia classic hemophilia see hemophilia A. , in which the clotting factor clot·ting factor n. Any of various plasma components involved in the clotting of blood, including fibrinogen, prothrombin, thromboplastin, and calcium ion. Also called coagulation factor. VIII is either deficient or defective. Hemophilia B hemophilia B n. A clotting disorder of blood resembling hemophilia A, caused by hereditary deficiency of factor IX. Also called Christmas disease. is characterized by deficient or defective factor IX. There are many useful materials in the BioRx hemophilia library.Visit http://www.biorx.net/hemophilia-library.php to view the most current listing of educational materials available. You can order any of the titles through your BioRx representative or simply call 1-866-44-BioRx. About BioRx Based in Cincinnati Ohio, BioRx is a national pharmacy specializing in highly customized care for the bleeding disorders community. As one of the nation's fastest growing providers of hemophilia clotting factors Clotting factors Substances in the blood that act in sequence to stop bleeding by forming a clot. Mentioned in: Partial Thromboplastin Time clotting factors, n. and other specialty pharmaceuticals the company's clinical staff reaches patients and physicians in 50 states. To learn more about BioRx and its products and services visit www.biorx.net. To request a jpg file of the Calendar cover art, email jcline@biorx.net |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion